Chorionic Gonadotropin
Chorionic Gonadotropin is a hormone medication that mimics luteinizing hormone (LH) to stimulate ovulation in women undergoing fertility treatments and support testosterone production in men with certain hormonal deficiencies. It is commonly used in assisted reproductive technologies and to treat conditions like cryptorchidism in children.
A hormone medication used for fertility treatments and hormonal disorders in both men and women.
Key facts at a glance
- ATC
- G03GA01
- RxNorm
- 4986
- Generic
- Chorionic Gonadotropin
- Class
- atc-g03
- Brands
- Chorulon, Pregnyl, Novarel, Ovidrel
- Availability
- rx
- Lactation
- unknown
- Routes
- —
- Forms
- prefilled syringe, solution
- Regions
- US, EU, CN, JP
- Monitoring
- —
This page is for informational purposes only.
Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.
Dosage and administration
- Usual dose
- 5000 units once daily
- Maximum
- consult physician
- Frequency
- once daily
- Instructions
- Follow physician instructions
- Duration limits
- as prescribed
- Monitoring
- standard
- Usual dose
- 1000 units twice daily
- Maximum
- consult physician
- Frequency
- every 12 hours
- Instructions
- Follow physician instructions
- Duration limits
- as prescribed
- Monitoring
- standard
- Usual dose
- 2500 units daily
- Maximum
- consult physician
- Frequency
- once daily
- Instructions
- Follow physician instructions
- Duration limits
- as prescribed
- Monitoring
- standard
Overdose information
Special Populations
8 groupspregnancy
first trimesteravoid if possible
avoid use during pregnancy unless benefits outweigh risks; contraindicated for fertility purposes during established pregnancy
regular fetal monitoring
Use of this medication in this population requires careful consideration of risks and benefits.
pregnancy
second trimesteruse only if clearly needed
use only under close medical supervision if benefits outweigh risks
regular prenatal monitoring
Use with caution and monitor for adverse effects.
pregnancy
third trimesteruse only if clearly needed
use only under close medical supervision if benefits outweigh risks
regular prenatal monitoring and fetal growth assessment
Use with caution and monitor for adverse effects.
lactation
breastfeedinguse with caution
limited data available; use only if benefits outweigh potential risks to nursing infant
monitor infant for any adverse effects
pediatric_age
prepubertalweight-based dosing under specialist supervision
used for cryptorchidism and hypogonadotropic hypogonadism in males; should be administered by experienced pediatric endocrinologist
monitor growth, bone age, and pubertal development
Use with caution and monitor for adverse effects.
geriatric
elderly malestart with lower dose and adjust based on response
used for hypogonadotropic hypogonadism; monitor cardiovascular status closely
monitor testosterone levels, prostate health, and cardiovascular parameters
Use with caution and monitor for adverse effects.
renal_impairment
mild to moderateno specific dose adjustment recommended but use with caution
use with caution; limited data on pharmacokinetics in renal impairment
monitor renal function and clinical response
Use with caution and monitor for adverse effects.
hepatic_impairment
mild to moderateno specific dose adjustment recommended but use with caution
use with caution; limited data on pharmacokinetics in hepatic impairment
monitor liver function and clinical response
Use with caution and monitor for adverse effects.
Statistics and clinical data
FDA approval year
First FDA approval for hCG formulations
Drug class
Hormone therapy - glycoprotein hormone
Primary therapeutic uses
Common therapeutic applications in reproductive medicine
Route of administration
Standard administration routes for hCG products
Treats female infertility by triggering ovulation, addresses male hypogonadotropic hypogonadism, and corrects cryptorchidism in children. Also used in assisted reproductive technologies.
Mimics luteinizing hormone (LH) by binding to LH receptors in the ovaries and testes, stimulating ovulation in women and testosterone production in men.
Requires careful monitoring for ovarian hyperstimulation syndrome in women and potential precocious puberty or gynecomastia in men. Should not be used during pregnancy except for ovulation induction.
Contraindications
Conditions and patient states where this medication should be avoided or used with caution.
Do not use (1)
Known allergy to this medication or its components
Use caution (1)
Consult healthcare provider for benefits vs risks assessment
Official drug label
WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 24, 2026. · Read our editorial policy